AtriCure

ATRC67

$35.310.00%$0.00

ATRC67

$35.31

0.00%$0.00

Performance History

Key Stats
Open	$38.02
Prev. Close	$38.20
EPS	-0.83
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	36.38	38.18
52 Week Range	18.94	43.00

Ratios







EPS	-0.83

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About AtriCure (ATRC)

AtriCure Inc. (ATRC) is a medical device company that develops and sells innovative solutions for the treatment of atrial fibrillation (AF) and other cardiac conditions. The company's products are designed to improve patient outcomes and reduce healthcare costs. With a focus on minimally invasive procedures, AtriCure offers a range of tools and technologies that enable surgeons to perform precise and effective cardiac ablation procedures. Ablation therapy is a treatment option for patients with AF that involves creating scar tissue in the heart to disrupt abnormal electrical signals and restore normal heart rhythm.

AtriCure's flagship product, the AtriClip, is a device used during open-heart surgery to close the left atrial appendage (LAA), the area of the heart most commonly associated with AF-related blood clots. By closing off the LAA, the AtriClip can significantly reduce the risk of stroke in patients with AF. In addition to the AtriClip, AtriCure offers a range of other ablation devices, including the CryoICE Cryoablation System, which uses extreme cold to create scar tissue in the heart, and the EPi-Sense Coagulation System, which uses radiofrequency energy to ablate cardiac tissue.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Michael H. Carrel
Headquarters: Mason
Employees: 1050
Exchange: NASDAQ

Keep an eye on AtriCure

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is AtriCure 's (ATRC) price per share?

The current price per share for AtriCure (ATRC) is $35.31. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for AtriCure (ATRC)?

For AtriCure (ATRC), the 52-week high is $43, which is 21.78% from the current price. The 52-week low is $18.94, the current price is 86.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is AtriCure (ATRC) a growth stock?

AtriCure (ATRC) has shown an average price growth of -3.55% over the past three years. It has received a score of 22 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AtriCure as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is AtriCure (ATRC) stock price performance year to date (YTD)?

As of the latest data, AtriCure (ATRC) has a year-to-date price change of -0.03%. Over the past month, the stock has experienced a price change of 27.93%. Over the last three months, the change has been 56.72%. Over the past six months, the figure is 61.31%. Looking at a longer horizon, the five-year price change stands at 25.7%.

help

Is AtriCure (ATRC) a profitable company?

AtriCure (ATRC) has a net income of -$30.44M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 75.23% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -6.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $399.24M, with a revenue growth rate of 20.84%, providing insight into the company's sales performance and growth. The gross profit is $300.37M. Operating income is noted at -$26.68M. Furthermore, the EBITDA is -$16.07M.

help

What is the market capitalization of AtriCure (ATRC)?

AtriCure (ATRC) has a market capitalization of $1.72B. The average daily trading volume is 35.31, indicating the stock's liquidity and investor engagement.